- Company
-
- Aifinyo AG
- Aixtron SE
- Berentzen Gruppe AG
- Amadeus Fire AG
- Brain Biotech AG
- Carl Zeiss Meditec AG
- Cherry SE
- Deutz AG
- Edag Engineering Group AG
- ElringKlinger AG
- Encavis AG
- Energiekontor AG
- Gerresheimer AG
- Hypoport SE
- Jost Werke SE
- Knaus Tabbert AG
- LEG Immobilien SE
- Mister Spex SE
- Mountain Alliance AG
- Mutares SE
- Nemetschek SE
- PSI Software SE
- Rational AG
- RENK Group AG
- Schaltbau Holding AG
- SFC Energy AG
- Sixt SE
- Talanx AG
- USU Software AG
- Varta AG
- voxeljet AG
- Verve Group SE
- Wacker Chemie AG
- Zeal Network SE
- Presentations
- Index
- Blog
- About
🇩🇪 Germany · MDAX · Pharma & MedTech
Gerresheimer AG Innovating pharma containment & drug delivery
A global systems and solutions provider to the pharmaceutical, biotech, and cosmetics industries delivering containment, drug-delivery devices, and medical solutions that bring critical therapies safely to patients worldwide.
GXI
Ticker
MDAX
Index
Pharma
Sector
DE 🇩🇪
HQ
1864
Founded
seat11a · Gerresheimer video hub
Gerresheimer AG Investor Relations Video Hub
All CEO & CFO video presentations from Gerresheimer AG filter by format below to find what you need.
Financial Results
Gerresheimer AG Financial Results H1 2024 | Strong Growth & Strategic Investments
Join IR Scott McCollister for Wacker Chemie AG's Q1 2023 financial results, revealing the company's performance across divisions and its strategic outlook for future growth under Strategy 2030.
Watch presentation
Drug Delivery
Pens, auto-injectors, pumps & inhalers
Pharma Containment
Vials, ampoules, syringes & bottles
Medical Devices
Digital therapy & specialty solutions
Global Network
35 sites across 16 countries
Headquarters
Gerresheimer AG
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Company overview
Innovating pharma containment & drug delivery
Gerresheimer is an innovative systems and solutions provider, serving as a global partner to the pharmaceutical, biotech, and cosmetics industries. The company delivers a broad portfolio of pharmaceutical containment solutions, drug-delivery systems, and medical devices, alongside specialised solutions for the wider health sector helping its customers bring critical therapies to market safely and at scale.
Comprehensive Product Range
The product portfolio includes digital therapy support tools, medication pumps, syringes, pens, auto-injectors, and inhalers. It is complemented by a wide variety of primary packaging solutions including vials, ampoules, tablet containers, infusion bottles, droppers, and syrup bottles addressing diverse therapeutic categories from biologics and parenterals to oral and topical applications.
Global Footprint
Gerresheimer operates 35 production sites across 16 countries in Europe, the Americas, and Asia. This international footprint allows the company to maintain a strong global presence while producing locally for regional markets ensuring efficient supply chains, regulatory proximity, and high market responsiveness for both established and emerging customers.
Financial Performance and Market Presence
With around 12,000 employees, Gerresheimer generated approximately €2 billion in revenue in 2023. The company is listed on the Frankfurt Stock Exchange and included in the MDAX index (ISIN: DE000A0LD6E6), reflecting its strong market position and the financial stability that underpins continued investment in capacity, automation, and high-value drug-delivery innovation.
Want your company
on seat11a?
Join Gerresheimer and 100+ listed companies reaching institutional investors through CEO and CFO video presentations.
